National Institute for Korean Medicine Development to Support Investment Attraction for Promising Korean Medicine Companies in Daegu and Gyeongbuk

Company Assessments, Customized Consulting, and Investment Consultations

The National Institute for Korean Medicine Development (President Koh Hoyoun) is recruiting companies to participate in the “2026 Customized Consulting and Investment Attraction Support Program for Korean Medicine Enterprises.”

Approximately 10 companies will be selected.

This program has been prepared to discover promising Korean medicine-related companies in the Daegu and Gyeongbuk regions and to strengthen their investment attraction capabilities and growth foundations.

National Institute for Korean Medicine Development Building Exterior

Eligible applicants include pharmaceutical, food, cosmetics, medical device, and healthcare companies related to Korean medicine that are located in the Daegu and Gyeongbuk regions.

Selected companies will undergo professional assessment to review their business models and investment readiness levels, and will receive customized consulting based on the assessment results.

The program aims to help companies clarify their investment attraction strategies and support them in progressing to actual investment consultations.

The application period runs until August 21, 2026.

Companies wishing to participate should submit the application form and related documents via email.

For details on the application process and required documents, please visit the National Institute for Korean Medicine Development website.

This content was produced with the assistance of AI translation services.